Beam Therapeutics Inc. (BEAM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 32.17 |
| Open | 32.72 |
| Bid | 33.11 x 300 |
| Ask | 33.20 x 300 |
| Day's range | 32.35 - 34.09 |
| 52-week range | 16.95 - 49.50 |
| Volume | |
| Avg. volume | 1,336,464 |
| Market cap | 2.728B |
| Beta (5Y monthly) | 1.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.60 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 50.46 |
ZacksBeam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
Beam Therapeutics (BEAM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Investor's Business DailyBeam Therapeutics Stock Earns RS Rating Jump To 85
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Beam Therapeutics stock now clears that threshold, with a jump from 65 to 85 Wednesday. IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score.
ZacksBeam Therapeutics' (BEAM) CFO to Step Down, Stock Declines
Beam Therapeutics' (BEAM) current chief financial officer, Terry-Ann Burrell, is set to step down from her role on Aug 9. The stock falls 4.7%.
© 2024 Yahoo. All rights reserved.